178 related articles for article (PubMed ID: 26633560)
41. [NTRK Fusions: A new way of treatment for gastro-intestinal tumor?].
Ouali K; Pellat A; Cohen R; Svrcek M; Penault-Llorca F; André T
Bull Cancer; 2020 Apr; 107(4):447-457. PubMed ID: 32067719
[TBL] [Abstract][Full Text] [Related]
42. Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions.
Singh H; Li YY; Spurr LF; Shinagare AB; Abhyankar R; Reilly E; Brais LK; Nag A; Ducar MD; Thorner AR; Shapiro GI; Keller RB; Siletti C; Clark JW; Farago AF; Lin JJ; Demetri GD; Gujrathi R; Kulke MH; MacConaill LE; Ligon AH; Sicinska E; Meyerson ML; Meyerhardt JA; Cherniack AD; Wolpin BM; Ng K; Giannakis M; Hornick JL; Cleary JM
Clin Cancer Res; 2021 Mar; 27(6):1695-1705. PubMed ID: 33414136
[TBL] [Abstract][Full Text] [Related]
43. Detection of an
Lai AZ; Schrock AB; Erlich RL; Ross JS; Miller VA; Yakirevich E; Ali SM; Braiteh F
Oncologist; 2017 Jul; 22(7):774-779. PubMed ID: 28507204
[TBL] [Abstract][Full Text] [Related]
44. Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings.
McGraw CM; Mahida S; Jayakar P; Koh HY; Taylor A; Resnick T; Rodan L; Schwartz MA; Ejaz A; Sankaran VG; Berry G; Poduri A
Ann Clin Transl Neurol; 2021 Mar; 8(3):716-722. PubMed ID: 33497533
[TBL] [Abstract][Full Text] [Related]
45. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine.
Miles MA; Hawkins CJ
Cell Death Dis; 2017 Oct; 8(10):e3062. PubMed ID: 28981092
[TBL] [Abstract][Full Text] [Related]
46. Entrectinib, a new multi-target inhibitor for cancer therapy.
Jiang Q; Li M; Li H; Chen L
Biomed Pharmacother; 2022 Jun; 150():112974. PubMed ID: 35447552
[TBL] [Abstract][Full Text] [Related]
47. Identification and characterization of a novel
Milione M; Ardini E; Christiansen J; Valtorta E; Veronese S; Bosotti R; Pellegrinelli A; Testi A; Pietrantonio F; Fucà G; Wei G; Murphy D; Siena S; Isacchi A; De Braud F
Oncotarget; 2017 Aug; 8(33):55353-55360. PubMed ID: 28903424
[TBL] [Abstract][Full Text] [Related]
48. CAD mutations and uridine-responsive epileptic encephalopathy.
Koch J; Mayr JA; Alhaddad B; Rauscher C; Bierau J; Kovacs-Nagy R; Coene KL; Bader I; Holzhacker M; Prokisch H; Venselaar H; Wevers RA; Distelmaier F; Polster T; Leiz S; Betzler C; Strom TM; Sperl W; Meitinger T; Wortmann SB; Haack TB
Brain; 2017 Feb; 140(2):279-286. PubMed ID: 28007989
[TBL] [Abstract][Full Text] [Related]
49. Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of
